Skip to main content
. 2017 Apr 19;18(4):835. doi: 10.3390/ijms18040835

Figure 3.

Figure 3

Effects of SAK-HV treatment on proliferation-related pathways (p38 MAPK, ERK, JNK, and PI3K/AKT) and the proliferation effector protein, c-Myc, in RAW264.7 cells at multiple time points (* p < 0.05; ** p < 0.01; *** p < 0.001). (A) The Western blot analysis for proliferation-related pathways (n = 3); (B–H) The bands quantification for Western blot analysis above. The RAW264.7 cells were treated with SAK-HV (1 μM) to determine its effects on the proliferation-related pathways via Western blot at multiple time points (0, 0.5, 1, 3, 6, 12, 24, and 48 h).